United States - English - NLM (National Library of Medicine)

teva parenteral medicines, inc. - metoclopramide hydrochloride (unii: w1792a2rvd) (metoclopramide - unii:l4yeb44i46) - metoclopramide 5 mg in 1 ml - metoclopramide injection is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis. metoclopramide injection is indicated for the prophylaxis of vomiting associated with emetogenic cancer chemotherapy. metoclopramide injection is indicated for the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable. metoclopramide injection may be used to facilitate small bowel intubation in adults and pediatric patients in whom the tube does not pass the pylorus with conventional maneuvers. metoclopramide injection may be used to stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examination of the stomach and/or small intestine. metoclopramide should not be used whenever stimulation of gastrointestinal motility might be dangerous, e.g., in the presence of gastrointestinal hemorrhage, mechanical obstruction, or perforation. metoclopramide is contraindicat

United States - English - NLM (National Library of Medicine)

hospira, inc. - metoclopramide hydrochloride (unii: w1792a2rvd) (metoclopramide - unii:l4yeb44i46) - metoclopramide 5 mg in 1 ml - diabetic gastroparesis (diabetic gastric stasis) metoclopramide is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis. the prevention of nausea and vomiting associated with emetogenic cancer chemotherapy metoclopramide injection, usp is indicated for the prophylaxis of vomiting associated with emetogenic cancer chemotherapy. the prevention of postoperative nausea and vomiting metoclopramide injection, usp is indicated for the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable. small bowel intubation metoclopramide injection, usp may be used to facilitate small bowel intubation in adults and pediatric patients in whom the tube does not pass the pylorus with conventional maneuvers. radiological examination metoclopramide injection, usp may be used to stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examination of the stomach and/or small intestine. metoclopramide should not be used whenever stimulation of gastrointestinal motility might be dangerous, e.g., in the presence of gastrointestinal hemorrhage, mechanical obstruction or perforation. metoclopramide is contraindicated in patients with pheochromocytoma because the drug may cause a hypertensive crisis, probably due to release of catecholamines from the tumor. such hypertensive crises may be controlled by phentolamine. metoclopramide is contraindicated in patients with known sensitivity or intolerance to the drug. metoclopramide should not be used in epileptics or patients receiving other drugs which are likely to cause extrapyramidal reactions, since the frequency and severity of seizures or extrapyramidal reactions may be increased.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - metoclopramide hydrochloride (unii: w1792a2rvd) (metoclopramide - unii:l4yeb44i46) - metoclopramide 10 mg - metoclopramide tablets, usp are indicated for the: limitations of use: metoclopramide tablets, usp are not recommended for use in pediatric patients due to the risk of developing tardive dyskinesia (td) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates [see use in specific populations (8.4)]. metoclopramide tablets are contraindicated: risk summary published studies, including retrospective cohort studies, national registry studies, and meta-analyses, do not report an increased risk of adverse pregnancy-related outcomes with use of metoclopramide during pregnancy. there are potential risks to the neonate following exposure in utero to metoclopramide during delivery [see clinical considerations]. in animal reproduction studies, no adverse developmental effects were observed with oral administration of metoclopramide to pregnant rats and rabbits at exposures about 6 and 12 times the maximum recommended human dose (mrhd) [see data] . the estimated background risk of major b

Israel - English - Ministry of Health

rafa laboratories ltd - metoclopramide hydrochloride - solution for injection - metoclopramide hydrochloride 5 mg/ml - metoclopramide - metoclopramide - metoclopramide is an antiemetic and stimulates gi motility. adult population: pramin is indicated in adults for: - prevention of postoperative nausea and vomiting (ponv) - prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv) - prevention of nausea and vomiting caused by radiation therapy -symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. in migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption. - diabetic gastroparesis - to faciliate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) (injection only). pediatric population. pramin is indicated in children aged 1 to 18 years for: - second line-therapy: treatment of established postoperative nausea and vomiting (ponv) - second-line therapy: prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv) - to facilitate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) (injection only)

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

imeks pharma sdn. bhd. - metoclopramide hydrochloride monohydrate -

Israel - English - Ministry of Health

david margalit & co.ltd - metoclopramide hydrochloride - solution for injection - metoclopramide hydrochloride 5 mg/ml - metoclopramide - metoclopramide baxter 5 mg/ml is indicated in adults for: - prevention of postoperative nausea and vomiting (ponv) - prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv) - prevention of nausea and vomiting caused by radiation therapy - symptomatic treatment of nausea and vomiting, including nausea and vomiting caused by migraine attack. in migraine attacks, metoclopramide can be used concomitantly with oral analgesics to improve their absorption. - diabetic gastroparesis - to faciliate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) ) (injection only) pediatric population. metoclopramide baxter 5 mg/ml is indicated in children aged 1 to 18 years for: - second line-therapy: treatment of established postoperative nausea and vomiting (ponv) - second-line therapy: prevention of delayed nausea and vomiting caused by chemotherapy (delayed cinv) - to facilitate diagnostic procedures (ie, to faciliate small bowel intubation and as an aid in radiological examinations) (injection only).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - metoclopramide hydrochloride - parenteral liquid/solution/suspension - metoclopramide hydrochloride anilide/aniline active 5.0 mg/ml - central nervous system - cat | dog | bitch | castrate | cat - queen | cat - tom | kitten | puppy - anti-emetic

Ireland - English - HPRA (Health Products Regulatory Authority)

le vet beheer b.v. - metoclopramide hydrochloride - solution for injection - 2.5 mg/ml - metoclopramide - canine, feline - neurological preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

ceva santé animale - metoclopramide hydrochloride - solution for injection - 5 milligram(s)/millilitre - metoclopramide - cats, dogs - miscellaneous

Ireland - English - HPRA (Health Products Regulatory Authority)

le vet beheer b.v. - metoclopramide hydrochloride monohydrate - solution for injection - 2.5 milligram(s)/millilitre - metoclopramide - cats, dogs - neurological preparations